The approval of oral semaglutide, an oral GLP-1 receptor agonist, could mark the beginning of a new era in the treatment of diabetes. We sat down with PIONEER investigator Vanita Aroda, MD, of Brigham and Women's, to learn more about the impact of this approval.

Discussing how changing seasons and weather impact allergy and asthma sufferers with Dr. Lakiea Wright, a board-certified allergist at Brigham and Women's and the medical director of US clinical affairs at Thermo Fisher Scientific. For more information and the latest news in allergy, asthma, and immunology care head to MDMagazine.com

Discussing the known facts and potential dangers of vaping and e-cigarette use with Albert Rizzo, MD, chief medical officer of the American Lung Association. For more information and the latest news in respiratory care, head to MDMagazine.com

Dhruv Kazi, MD, of Beth Israel Deaconess Medical Center, discusses a recent study he led examining use of polypill in several low- and middle-income countries. In this episode, Kazi shares his insights on the study and why polypill seems to be effective but has not become more popular as a treatment for CVD. 

Discussing use of AI to determine overall physiological health through a 12-lead ECG. For more on AI in health and the latest in cardiology, be sure to head to MDMagazine.com

Discussing transcatheter aortic valve replacement with Dr. Tsuyoshi Kaneko and Dr. Sameer Hirji, both of Brigham and Women's Hospital. For more on TAVR and the latest in cardiology, be sure to head to MDMagazine.com